Liraglutide treatment reverses unconventional cellular defects in induced pluripotent stem cell-derived β cells harboring a partially functional WFS1 variant
Silvia Torchio, Gabriel Siracusano, Federica Cuozzo, Valentina Zamarian, Silvia Pellegrini, Fabio Manenti, Riccardo Bonfanti, Giulio Frontino, Valeria Sordi, Raniero Chimienti, Lorenzo Piemonti
This study shows liraglutide treatment restores glucose-stimulated insulin secretion and reduces apoptosis in WFS1 mutant iPSC-derived β cells.
Diabetes · Apr 9, 2025Peer-reviewedCell Biology